Nautilus Biotechnolgy
NAUT
NAUT
76 hedge funds and large institutions have $191M invested in Nautilus Biotechnolgy in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 26 increasing their positions, 22 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
15.03% more ownership
Funds ownership: 36.09% → 51.11% (+15%)
1% more funds holding
Funds holding: 75 → 76 (+1)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
76
Holding in Top 10
3
Calls
$74K
Puts
$5K
Top Buyers
| 1 | +$10.4M | |
| 2 | +$1.43M | |
| 3 | +$473K | |
| 4 |
BlackRock
New York
|
+$463K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$323K |
Top Sellers
| 1 | -$4.58M | |
| 2 | -$1.76M | |
| 3 | -$143K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$123K |
| 5 |
CC
Clearline Capital
New York
|
-$90.3K |